Skip to main content
HHS Logo U.S. Department of Health & Human Services NIH logo National Institutes of Health
  1. Home
  2. Research
  3. Pre-Clinical Innovation

Pre-Clinical Innovation

Craig Thomas, Ph.D., views and discusses the results of a drug screen with scientists Michele Ceribelli, Ph.D., and Scott Hoyt, Ph.D.
Potential New Drug Combinations for Childhood Cancers

To help address challenges in treating children with cancer, a team of NCATS researchers is rethinking treatment approaches for several difficult-to-treat childhood cancers.

A family of proteins, including the cancer target protein NSD2, surround a cell’s nucleosome.
New Approach to Identify Potential Cancer Drugs

NCATS researchers develop a series of assays (tests) to identify compounds that disrupt a driver of several cancers.

Improving the Drug Development Process

Creating and testing innovative methods to improve and accelerate the drug development process and find new treatments for patients faster.

Repurposing Drugs

Discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside.

Testing & Predictive Models

Developing better model systems for drug and toxicity testing.

Core Technologies

Using state-of-the-art resources to enable the ongoing operation of all NCATS translational research activities.

Improving the Drug Development Process

Creating and testing innovative methods to improve and accelerate the drug development process and find new treatments for patients faster.

Repurposing Drugs

Discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside.

Testing & Predictive Models

Developing better model systems for drug and toxicity testing.

Core Technologies

Using state-of-the-art resources to enable the ongoing operation of all NCATS translational research activities.